Cost-Effectiveness of Direct Transfer of Acute Ischemic Stroke Patients to Angiography Suite
Author(s)
Nguyen C1, Lahr MMH2, Van der Zee DJ3, Van Voorst H4, Ribo M5, Roos YBWEM4, Buskens E2, Uyttenboogaart M2
1University of Groningen, Groningen, GR, Netherlands, 2University Medical Center Groningen, Groningen, Netherlands, 3University of Groningen, Groningen, Netherlands, 4Amsterdam University Medical Center, Amsterdam, Netherlands, 5Hospital Universitari Vall d’Hebron, Barcelona, Spain
Presentation Documents
OBJECTIVES: Patients with acute ischemic stroke due to large vessel occlusion (LVO), when eligible, are usually transferred from the emergency room to the angiography suite to undergo endovascular thrombectomy (EVT). Recently, the strategy of direct transfer of suspected LVO patients to the angiography suite (DTAS) has been shown to improve functional outcome. The present study aims to evaluate the cost-effectiveness of the DTAS strategy versus transfer of suspected LVO patients to the emergency room (ITER).
METHODS: A decision-analytic and attached Markov model were developed to estimate the cost-effectiveness of the DTAS strategy versus the ITER strategy from a Dutch healthcare perspective with a ten-year time horizon. The primary outcome was the incremental cost-effectiveness ratio (ICER) with the Dutch thresholds (€50,000 and €80,000 per quality-adjusted life year (QALY)). Uncertainty of input parameters was assessed using one-way sensitivity analysis, scenario analysis and probabilistic sensitivity analysis.
RESULTS: The DTAS strategy yielded 0.32 additional QALYs at an additional €7,319, resulting in an ICER of €22,807 per QALY compared to the ITER strategy. The ICER varied from €24,768 to €32,045/QALY in different scenarios. The ICER was particularly sensitive to the utility scores of the more advantageous, i.e., long-term care-independent stroke outcomes and the EVT costs. The probabilistic sensitivity analysis showed that the DTAS strategy had an 89% and 96% likelihood of being cost-effective at a willingness-to-pay threshold of €50,000/QALY and €80,000/QALY, respectively.
CONCLUSIONS: The DTAS strategy had robust cost-effectiveness for patients suspected of LVO. Implementation of the DTAS strategy should be considered to improve the workflow of EVT.
Conference/Value in Health Info
Value in Health, Volume 25, Issue 12S (December 2022)
Code
EE558
Topic
Economic Evaluation, Methodological & Statistical Research, Study Approaches
Topic Subcategory
Cost-comparison, Effectiveness, Utility, Benefit Analysis, Decision Modeling & Simulation
Disease
STA: Surgery